(Q46661645)

English

Effectiveness of amphotericin B lipid complex (ABLC) treatment in allogeneic hematopoietic cell transplant (HCT) recipients with invasive aspergillosis (IA).

scientific article

In more languages

Statements

scholarly article

1 reference

Europe PubMed Central

24 December 2017

http://europepmc.org/abstract/MED/16113663

Effectiveness of amphotericin B lipid complex (ABLC) treatment in allogeneic hematopoietic cell transplant (HCT) recipients with invasive aspergillosis (IA). (English)

1 reference

Europe PubMed Central

24 December 2017

http://europepmc.org/abstract/MED/16113663

0 references

invasive aspergillosis

1 reference

based on heuristic

inferred from title

1 reference

based on heuristic

inferred from title

author name string

Ito JI

1

1 reference

Europe PubMed Central

24 December 2017

http://europepmc.org/abstract/MED/16113663

Chandrasekar PH

2

1 reference

Europe PubMed Central

24 December 2017

http://europepmc.org/abstract/MED/16113663

Hooshmand-Rad R

3

1 reference

Europe PubMed Central

24 December 2017

http://europepmc.org/abstract/MED/16113663

language of work or name

0 references

publication date

1 November 2005

1 reference

Europe PubMed Central

24 December 2017

http://europepmc.org/abstract/MED/16113663

Bone Marrow Transplantation

1 reference

Europe PubMed Central

24 December 2017

http://europepmc.org/abstract/MED/16113663

36

1 reference

Europe PubMed Central

24 December 2017

http://europepmc.org/abstract/MED/16113663

10

1 reference

Europe PubMed Central

24 December 2017

http://europepmc.org/abstract/MED/16113663

873-877

1 reference

Europe PubMed Central

24 December 2017

http://europepmc.org/abstract/MED/16113663

https://scigraph.springernature.com/pub.10.1038/sj.bmt.1705143

0 references

Invasive mold infections in allogeneic bone marrow transplant recipients.

1 reference

https://api.crossref.org/works/10.1038%2FSJ.BMT.1705143

21 January 2018

Epidemiology and outcome of mould infections in hematopoietic stem cell transplant recipients

1 reference

https://api.crossref.org/works/10.1038%2FSJ.BMT.1705143

21 January 2018

Aspergillosis case-fatality rate: systematic review of the literature

1 reference

https://api.crossref.org/works/10.1038%2FSJ.BMT.1705143

21 January 2018

Clinical significance of nephrotoxicity in patients treated with amphotericin B for suspected or proven aspergillosis

1 reference

https://api.crossref.org/works/10.1038%2FSJ.BMT.1705143

21 January 2018

The epidemiology of nephrotoxicity associated with conventional amphotericin B therapy

1 reference

https://api.crossref.org/works/10.1038%2FSJ.BMT.1705143

21 January 2018

Mortality and costs of acute renal failure associated with amphotericin B therapy

1 reference

https://api.crossref.org/works/10.1038%2FSJ.BMT.1705143

21 January 2018

Characterizing and predicting amphotericin B-associated nephrotoxicity in bone marrow or peripheral blood stem cell transplant recipients

1 reference

https://api.crossref.org/works/10.1038%2FSJ.BMT.1705143

21 January 2018

Voriconazole versus amphotericin B for primary therapy of invasive aspergillosis

1 reference

https://api.crossref.org/works/10.1038%2FSJ.BMT.1705143

21 January 2018

Amphotericin B lipid complex in the treatment of invasive fungal infections: results of the Collaborative Exchange of Antifungal Research (CLEAR), an industry-supported patient registry

1 reference

https://api.crossref.org/works/10.1038%2FSJ.BMT.1705143

21 January 2018

Study of renal safety in amphotericin B lipid complex-treated patients

1 reference

https://api.crossref.org/works/10.1038%2FSJ.BMT.1705143

21 January 2018

Retrospective study of the renal effects of amphotericin B lipid complex when used at higher-than-recommended dosages and longer durations compared with lower dosages and shorter durations in patients with systemic fungal infections

1 reference

https://api.crossref.org/works/10.1038%2FSJ.BMT.1705143

21 January 2018

Prediction of creatinine clearance from serum creatinine

1 reference

https://api.crossref.org/works/10.1038%2FSJ.BMT.1705143

21 January 2018

A double-blind, randomized, controlled trial of amphotericin B colloidal dispersion versus amphotericin B for treatment of invasive aspergillosis in immunocompromised patients

1 reference

https://api.crossref.org/works/10.1038%2FSJ.BMT.1705143

21 January 2018

Efficacy and safety of caspofungin for treatment of invasive aspergillosis in patients refractory to or intolerant of conventional antifungal therapy

1 reference

https://api.crossref.org/works/10.1038%2FSJ.BMT.1705143

21 January 2018

Defining opportunistic invasive fungal infections in immunocompromised patients with cancer and hematopoietic stem cell transplants: an international consensus.

1 reference

https://api.crossref.org/works/10.1038%2FSJ.BMT.1705143

21 January 2018

Lipid formulations of amphotericin B: clinical efficacy and toxicities

1 reference

https://api.crossref.org/works/10.1038%2FSJ.BMT.1705143

21 January 2018

Renal effects of amphotericin B lipid complex.

1 reference

https://api.crossref.org/works/10.1038%2FSJ.BMT.1705143

21 January 2018

Toward more effective antifungal therapy: the prospects of combination therapy.

1 reference

https://api.crossref.org/works/10.1038%2FSJ.BMT.1705143

21 January 2018

Epidemiology ofAspergillusInfections in a Large Cohort of Patients Undergoing Bone Marrow Transplantation

1 reference

https://api.crossref.org/works/10.1038%2FSJ.BMT.1705143

7 January 2021

based on heuristic

inferred from DOI database lookup

Acute renal failure following bone marrow transplantation: a retrospective study of 272 patients

1 reference

https://api.crossref.org/works/10.1038%2FSJ.BMT.1705143

7 January 2021

based on heuristic

inferred from DOI database lookup

Efficacy of amphotericin B lipid complex injection (ABLC) in bone marrow transplant recipients with life-threatening systemic mycoses

1 reference

https://api.crossref.org/works/10.1038%2FSJ.BMT.1705143

7 January 2021

based on heuristic

inferred from DOI database lookup

Identifiers

10.1038/SJ.BMT.1705143

1 reference

Europe PubMed Central

24 December 2017

http://europepmc.org/abstract/MED/16113663

Dimensions Publication ID

0 references

1 reference

Europe PubMed Central

24 December 2017

http://europepmc.org/abstract/MED/16113663

ResearchGate publication ID

0 references

Sitelinks

Wikipedia(0 entries)

Wikibooks(0 entries)

Wikinews(0 entries)

Wikiquote(0 entries)

Wikisource(0 entries)

Wikiversity(0 entries)

Wikivoyage(0 entries)

Wiktionary(0 entries)

Multilingual sites(0 entries)

Retrieved from "https://www.wikidata.org/w/index.php?title=Q46661645&oldid=1969291039"